Boston Scientific stock tumbles 9% on trial results

Chronological Source Flow
Back

AI Fusion Summary

Boston Scientific shares dropped 9% after the company announced its latest trial failed to meet primary endpoints, sparking analyst downgrades and raising doubts about the company's product pipeline and future revenue.
30/03 21:47 investing.com
2 Πηγές
31/03 00:22 investing.com
Comments
Loading...
0